Published in Cancer Res on April 20, 2010
Cancer to bone: a fatal attraction. Nat Rev Cancer (2011) 4.08
Cross talk among TGF-β signaling pathways, integrins, and the extracellular matrix. Cold Spring Harb Perspect Biol (2011) 1.60
ATP6V1H Deficiency Impairs Bone Development through Activation of MMP9 and MMP13. PLoS Genet (2017) 1.39
Metastatic bone disease: role of transcription factors and future targets. Bone (2010) 1.30
Effect of zoledronate on oral wound healing in rats. Clin Cancer Res (2010) 0.98
Microarray and proteomic analysis of breast cancer cell and osteoblast co-cultures: role of osteoblast matrix metalloproteinase (MMP)-13 in bone metastasis. J Biol Chem (2011) 0.97
MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases. Breast Cancer Res (2011) 0.95
Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo. Breast Cancer Res (2012) 0.94
An MMP13-selective inhibitor delays primary tumor growth and the onset of tumor-associated osteolytic lesions in experimental models of breast cancer. PLoS One (2012) 0.93
Host response mechanisms in periodontal diseases. J Appl Oral Sci (2015) 0.90
Expression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancer. BMC Cancer (2014) 0.86
Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis. Oncogene (2012) 0.86
Protein arginine methyltransferase 7 promotes breast cancer cell invasion through the induction of MMP9 expression. Oncotarget (2015) 0.86
Membrane localization of membrane type 1 matrix metalloproteinase by CD44 regulates the activation of pro-matrix metalloproteinase 9 in osteoclasts. Biomed Res Int (2013) 0.85
Clusterin facilitates metastasis by EIF3I/Akt/MMP13 signaling in hepatocellular carcinoma. Oncotarget (2015) 0.84
Bone marrow as a metastatic niche for disseminated tumor cells from solid tumors. Bonekey Rep (2015) 0.81
Protein Expression Profiling of Giant Cell Tumors of Bone Treated with Denosumab. PLoS One (2016) 0.79
PAI-1, a target gene of miR-143, regulates invasion and metastasis by upregulating MMP-13 expression of human osteosarcoma. Cancer Med (2016) 0.79
Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenografts. Clin Exp Metastasis (2013) 0.79
SEMA6D Expression and Patient Survival in Breast Invasive Carcinoma. Int J Breast Cancer (2015) 0.79
Molecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targets. World J Clin Oncol (2014) 0.79
Multiple myeloma-derived MMP-13 mediates osteoclast fusogenesis and osteolytic disease. J Clin Invest (2016) 0.78
A cross-species analysis of a mouse model of breast cancer-specific osteolysis and human bone metastases using gene expression profiling. BMC Cancer (2011) 0.77
ANGPTL2 increases bone metastasis of breast cancer cells through enhancing CXCR4 signaling. Sci Rep (2015) 0.77
Immunolocalization of MMP9 and MMP2 in osteolytic metastasis originating from MDA-MB-231 human breast cancer cells. Mol Med Rep (2016) 0.76
Cancer-Osteoblast Interaction Reduces Sost Expression in Osteoblasts and Up-Regulates lncRNA MALAT1 in Prostate Cancer. Microarrays (Basel) (2015) 0.75
Current Evidence and Future Perspectives on HuR and Breast Cancer Development, Prognosis, and Treatment. Neoplasia (2016) 0.75
Matrix Metalloproteinases as Regulators of Periodontal Inflammation. Int J Mol Sci (2017) 0.75
Genome-wide gene expression analysis of chemoresistant pulmonary carcinoid cells. Lung Cancer (Auckl) (2010) 0.75
The Clinical Significance and Molecular Features of the Spatial Tumor Shapes in Breast Cancers. PLoS One (2015) 0.75
MMP-13 is one of the critical mediators of the effect of HDAC4 deletion on the skeleton. Bone (2016) 0.75
Bone metastasis-related signaling pathways in breast cancers stratified by estrogen receptor status. J Cancer (2017) 0.75
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
TGF-beta signal transduction. Annu Rev Biochem (1998) 17.83
Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer (2002) 12.45
Mechanisms of bone metastasis. N Engl J Med (2004) 10.40
Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res (1992) 9.02
Lysyl oxidase is essential for hypoxia-induced metastasis. Nature (2006) 8.28
Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev (2000) 8.24
KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer. Clin Cancer Res (2009) 6.10
Skeletal complications of malignancy. Cancer (1997) 5.41
TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J (1997) 4.48
Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem (1994) 3.64
Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest (1996) 3.44
Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol (2000) 2.87
MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell (2005) 2.65
TGF-beta signaling by Smad proteins. Adv Immunol (2000) 2.47
Mechanisms of bone metastasis. Cancer (1997) 2.29
Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res (1991) 2.26
Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice. J Clin Invest (2009) 2.09
The structure, regulation, and function of human matrix metalloproteinase-13. Crit Rev Biochem Mol Biol (2002) 1.78
The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis. Surg Oncol Clin N Am (2001) 1.77
The RANK/RANKL/OPG triad in cancer-induced bone diseases. Cancer Metastasis Rev (2006) 1.73
The lysyl oxidase inhibitor, beta-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cells. PLoS One (2009) 1.72
Crosstalk between cancer cells and bone microenvironment in bone metastasis. Biochem Biophys Res Commun (2005) 1.69
Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol (1997) 1.66
Cytokine regulation of metalloproteinase gene expression. J Cell Biochem (1993) 1.61
Identification of brain- and bone-specific breast cancer metastasis genes. Cancer Lett (2008) 1.54
Catabolism and turnover of collagens: collagenases. Methods Enzymol (1987) 1.44
A gene expression signature that defines breast cancer metastases. Clin Exp Metastasis (2008) 1.34
Expression of lumican in human breast carcinoma. Cancer Res (1998) 1.33
Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13). Eur J Biochem (1997) 1.26
Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions. Cancer Res (1997) 1.25
Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor. Am J Pathol (1998) 1.24
Expression of bone sialoprotein, a bone matrix protein, in human breast cancer. Cancer Res (1994) 1.24
Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand. Cancer Res (2008) 1.21
Expression of matrix metalloproteinase-9 in head and neck squamous cell carcinoma: a potential marker for prognosis. Clin Cancer Res (2004) 1.19
Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis. Nat Clin Pract Oncol (2006) 1.15
Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. Am J Pathol (1999) 1.10
Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer. Lung Cancer (2006) 1.07
Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13. Int J Cancer (2005) 1.05
Cathepsin G-mediated activation of pro-matrix metalloproteinase 9 at the tumor-bone interface promotes transforming growth factor-beta signaling and bone destruction. Mol Cancer Res (2009) 1.05
Factors regulating the growth of metastatic cancer in bone. Endocr Relat Cancer (1999) 1.04
Role of RANKL-induced osteoclast formation and MMP-dependent matrix degradation in bone destruction by breast cancer metastasis. Br J Cancer (2003) 1.01
Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx. J Pathol (1998) 0.99
Antisense oligonucleotides as a tool for gene functionalization and target validation. Biochim Biophys Acta (1999) 0.99
Expression of bone sialoprotein in primary human breast cancer is associated with poor survival. Int J Cancer (1996) 0.99
Transforming growth factor-beta signaling at the tumor-bone interface promotes mammary tumor growth and osteoclast activation. Cancer Sci (2008) 0.95
Tumor cell specific expression of MMP-2 correlates with tumor vascularisation in breast cancer. Int J Oncol (2002) 0.92
Drug properties of second-generation antisense oligonucleotides: how do they measure up to their predecessors? Curr Opin Investig Drugs (2001) 0.92
Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development. J Bone Miner Res (1996) 0.89
Enhanced expression and shedding of receptor activator of NF-kappaB ligand during tumor-bone interaction potentiates mammary tumor-induced osteolysis. Clin Exp Metastasis (2009) 0.82
MicroRNA-143 regulates adipocyte differentiation. J Biol Chem (2004) 6.78
Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol (2010) 4.80
IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol (2003) 4.64
Murine models to evaluate novel and conventional therapeutic strategies for cancer. Am J Pathol (2007) 3.03
Targeting the eukaryotic translation initiation factor 4E for cancer therapy. Cancer Res (2008) 3.02
Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity. J Clin Invest (2007) 3.01
STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest (2008) 2.95
MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell (2005) 2.65
Host CXCR2-dependent regulation of melanoma growth, angiogenesis, and experimental lung metastasis. Cancer Res (2009) 1.93
Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes. Nucleic Acids Res (2011) 1.84
Interstage mortality after the Norwood procedure: Results of the multicenter Single Ventricle Reconstruction trial. J Thorac Cardiovasc Surg (2012) 1.79
Rapid, noninvasive diagnosis of visceral leishmaniasis in India: comparison of two immunochromatographic strip tests for detection of anti-K39 antibody. J Clin Microbiol (2006) 1.75
Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis. Angiogenesis (2005) 1.69
Chemokines in tumor angiogenesis and metastasis. Cancer Metastasis Rev (2007) 1.63
Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavage. Oncogene (2004) 1.53
Competition for RISC binding predicts in vitro potency of siRNA. Nucleic Acids Res (2006) 1.44
Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma. Am J Clin Pathol (2006) 1.39
Severe childhood autosomal recessive muscular dystrophy, mental subnormality and chorea. Neurol India (2006) 1.39
Expression of CXCR1 and CXCR2 receptors in malignant melanoma with different metastatic potential and their role in interleukin-8 (CXCL-8)-mediated modulation of metastatic phenotype. Clin Exp Metastasis (2003) 1.39
miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma. Nat Med (2010) 1.35
hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy. Cancer Res (2010) 1.35
Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis. Clin Cancer Res (2009) 1.34
Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-α in breast cancer. Cancer Res (2013) 1.31
Repeat infective endocarditis: differentiating relapse from reinfection. Clin Infect Dis (2005) 1.26
Constitutive expression of growth regulated oncogene (gro) in human colon carcinoma cells with different metastatic potential and its role in regulating their metastatic phenotype. Clin Exp Metastasis (2004) 1.22
Control of RNA processing by a large non-coding RNA over-expressed in carcinomas. FEBS Lett (2011) 1.21
Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand. Cancer Res (2008) 1.21
Identification of novel PPARgamma target genes in primary human adipocytes. Gene (2005) 1.20
Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells. Cancer Res (2007) 1.18
Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases. Cancer Lett (2010) 1.18
Dose-dependent mesothelioma induction by intraperitoneal administration of multi-wall carbon nanotubes in p53 heterozygous mice. Cancer Sci (2012) 1.13
Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice. Cancer Immunol Immunother (2009) 1.12
Tumour-associated macrophage infiltration, neovascularization and aggressiveness in malignant melanoma: role of monocyte chemotactic protein-1 and vascular endothelial growth factor-A. Melanoma Res (2005) 1.12
Identification of functional cell adhesion molecules with a potential role in metastasis by a combination of in vivo phage display and in silico analysis. OMICS (2007) 1.11
Proteases as modulators of tumor-stromal interaction: primary tumors to bone metastases. Biochim Biophys Acta (2007) 1.07
High gene expression of semaphorin 5A in pancreatic cancer is associated with tumor growth, invasion and metastasis. Int J Cancer (2010) 1.05
Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS). Kidney Int (2003) 1.05
Cathepsin G-mediated activation of pro-matrix metalloproteinase 9 at the tumor-bone interface promotes transforming growth factor-beta signaling and bone destruction. Mol Cancer Res (2009) 1.05
Paracrine regulation of vascular endothelial growth factor--a expression during macrophage-melanoma cell interaction: role of monocyte chemotactic protein-1 and macrophage colony-stimulating factor. J Interferon Cytokine Res (2005) 1.03
Use of matrix metalloproteinase (MMP)-9 knockout mice demonstrates that MMP-9 activity is not absolutely required for G-CSF or Flt-3 ligand-induced hematopoietic progenitor cell mobilization or engraftment. Stem Cells (2003) 1.03
CXCL8 and its cognate receptors in melanoma progression and metastasis. Future Oncol (2010) 1.02
Interleukin-8-induced proliferation, survival, and MMP production in CXCR1 and CXCR2 expressing human umbilical vein endothelial cells. Microvasc Res (2002) 1.00
Characterization of Listeria monocytogenes isolated from Ganges water, human clinical and milk samples at Varanasi, India. Infect Genet Evol (2012) 1.00
Effect of heat therapy using magnetic nanoparticles conjugated with cationic liposomes on prostate tumor in bone. Prostate (2008) 1.00
Alkaloids: future prospective to combat leishmaniasis. Fitoterapia (2008) 0.99
Role of chemokine receptor CXCR2 expression in mammary tumor growth, angiogenesis and metastasis. J Carcinog (2011) 0.99
Functional proteomic analysis reveals the involvement of KIAA1199 in breast cancer growth, motility and invasiveness. BMC Cancer (2014) 0.99
Multi-walled carbon nanotubes translocate into the pleural cavity and induce visceral mesothelial proliferation in rats. Cancer Sci (2012) 0.99
Monocyte/macrophage recruitment, activation and differentiation modulate interleukin-8 production: a paracrine role of tumor-associated macrophages in tumor angiogenesis. In Vivo (2002) 0.98
Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, proinflammatory cytokines and lipid profile in newly diagnosed type 2 diabetes. Diabetes Res Clin Pract (2011) 0.97
Tumor-stromal interactions in bone metastasis. Curr Osteoporos Rep (2010) 0.97
Cranberry proanthocyanidins are cytotoxic to human cancer cells and sensitize platinum-resistant ovarian cancer cells to paraplatin. Phytother Res (2009) 0.97
Semaphorin 5A promotes angiogenesis by increasing endothelial cell proliferation, migration, and decreasing apoptosis. Microvasc Res (2009) 0.96
Anticancer effect of hyperthermia on prostate cancer mediated by magnetite cationic liposomes and immune-response induction in transplanted syngeneic rats. Prostate (2005) 0.96
Transforming growth factor-beta signaling at the tumor-bone interface promotes mammary tumor growth and osteoclast activation. Cancer Sci (2008) 0.95
Apoptotic and chemotherapeutic properties of iron (III)-salophene in an ovarian cancer animal model. Drug Des Devel Ther (2009) 0.94
Anti-proliferative and pro-apoptotic properties of 3-bromoacetoxy calcidiol in high-risk neuroblastoma. Chem Biol Drug Des (2007) 0.94
Small interfering RNA-mediated CXCR1 or CXCR2 knock-down inhibits melanoma tumor growth and invasion. Int J Cancer (2010) 0.94
CXCR1 and CXCR2 silencing modulates CXCL8-dependent endothelial cell proliferation, migration and capillary-like structure formation. Microvasc Res (2011) 0.94
Targeting CXCR2 enhances chemotherapeutic response, inhibits mammary tumor growth, angiogenesis, and lung metastasis. Mol Cancer Ther (2013) 0.93
Prospective randomized clinical trial comparing bite force in 2-mm locking plates versus 2-mm standard plates in treatment of mandibular fractures. J Oral Maxillofac Surg (2011) 0.93
Complete regression of experimental prostate cancer in nude mice by repeated hyperthermia using magnetite cationic liposomes and a newly developed solenoid containing a ferrite core. Prostate (2006) 0.93
Cancer prevention by bovine lactoferrin: from animal studies to human trial. Biometals (2010) 0.92
Transforming growth factor beta derived from bone matrix promotes cell proliferation of prostate cancer and osteoclast activation-associated osteolysis in the bone microenvironment. Cancer Sci (2008) 0.92
Anti-angiogenic activity of cranberry proanthocyanidins and cytotoxic properties in ovarian cancer cells. Int J Oncol (2011) 0.92
Regulation of constitutive and induced NF-kappaB activation in malignant melanoma cells by capsaicin modulates interleukin-8 production and cell proliferation. J Interferon Cytokine Res (2002) 0.90
Cathepsin G-mediated enhanced TGF-beta signaling promotes angiogenesis via upregulation of VEGF and MCP-1. Cancer Lett (2009) 0.90
Fighting against Leishmaniasis: search of alkaloids as future true potential anti-Leishmanial agents. Mini Rev Med Chem (2009) 0.90
Effect of a vitamin D(3) derivative (B3CD) with postulated anti-cancer activity in an ovarian cancer animal model. Invest New Drugs (2009) 0.89
Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma. Expert Opin Ther Targets (2010) 0.89
Cathepsin G recruits osteoclast precursors via proteolytic activation of protease-activated receptor-1. Cancer Res (2009) 0.88
A novel flavonoid C-glycoside from Sphaeranthus indicus L. (family Compositae). Molecules (2007) 0.88
Identification of TLR inducing Th1-responsive Leishmania donovani amastigote-specific antigens. Mol Cell Biochem (2011) 0.88
A comparison of traditional versus contemporary immunosuppressive regimens in pediatric heart recipients. J Pediatr (2013) 0.87
Involvement of macrophage inflammatory protein 1alpha (MIP1alpha) in promotion of rat lung and mammary carcinogenic activity of nanoscale titanium dioxide particles administered by intra-pulmonary spraying. Carcinogenesis (2010) 0.87
Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C. BMC Cancer (2012) 0.86
A medium-term, rapid rat bioassay model for the detection of carcinogenic potential of chemicals. Toxicol Pathol (2010) 0.86
The modification of siRNA with 3' cholesterol to increase nuclease protection and suppression of native mRNA by select siRNA polyplexes. Biomaterials (2010) 0.86
Chemotherapeutic effect of calcidiol derivative B3CD in a neuroblastoma xenograft model. Chem Biol Drug Des (2010) 0.86
Platelet-rich growth factor in oral and maxillofacial surgery. Natl J Maxillofac Surg (2012) 0.86